UC Blue Ash Rad Tech students maintain impressive tradition
Fri, June 21, 2019
Article has no nextliveshere tags assigned
Article has no topics tags assigned
Article has no colleges tags assigned
Description is empty
Article has no audiences tags assigned
Article has no units tags assigned
Contacts are empty
These messages will display in edit mode only.
Pancreatic cancer patient symposium Feb. 9
Provides info on latest in research, treatment
Pancreatic cancer is the nation’s No. 4 cancer killer, but a diagnosis is not a death sentence, as research and new potential therapies provide hope for patients each day.
To educate on these latest breakthroughs as well as the spectrum of the illness, including screening, evaluation, personalized treatment approaches and survivorship care, the University of Cincinnati (UC) Cancer Institute is hosting an educational event for patients, survivors, their families and the community.
Cooper Creek Event and Conference Center
The event, being held from 1 p.m. to 4 p.m. Saturday, Feb. 9, at the Cooper Creek Event and Conference Center, 4040 Cooper Rd., Blue Ash, will involve presentations from experts within the institute at UC, the community, patients and more.
Talks will touch on symptom management, nutritional guidelines and the patient experience of living with and surviving pancreatic cancer. Additionally, attendees will hear from caregivers and family members of those with the disease and will have an opportunity to ask UC experts questions. UC Health’s Integrative Medicine will be on hand, as well, to offer tips on mindful relaxation techniques.
“We hope this event will help raise awareness about pancreas cancer in the community and highlight new, groundbreaking treatment strategies,” adds Sameer Patel, MD, assistant professor of surgery at the UC College of Medicine, UC Health surgical oncologist and a member of the UC Cancer Institute.
Light refreshments will be provided. For more information, contact Kelly Hummel at 513-558-2030.
Featured photo of Sameer Patel, MD / Credit: Tommy Campbell, UC Health
Related Stories
WKRC-TV, Local 12: Building a better doctor day 1
Wed, June 19, 2019
UC selected to test new vaccine
Wed, June 19, 2019
UC will serve as one of several international locations to test an investigational vaccine to possibly treat cytomegalovirus in people getting kidney transplants. The study is designed to learn more about the safety and effectiveness of the HB-101 vaccine at preventing the CMV infection in people who are CMV-negative who receive kidney transplants from living donors who are CMV-positive.